ArticleClinical cancer research : an official journal of the American Association for Cancer Research2021

Patients with Biallelic BRCA1/2 Inactivation Respond to Olaparib Treatment Across Histologic Tumor Types.

Hanneke van der Wijngaart et al.PubMed ↗Publisher ↗

No numbers read from the abstract.